- conflicts or gaps
- [[{"topic": {"value": "YC Inactive vs operational/legal active status", "source_urls": ["https://www.ycombinator.com/companies/endpoint-health", "https://www.bizprofile.net/ca/palo-alto/endpoint-health-inc", "https://endpoint.health/"]}, "detail": {"value": "YC lists Status Inactive and all founders as Former Founders; CA SOS shows Active corporation in good standing; website and LinkedIn activity persist with no public shutdown announcement", "source_urls": ["https://www.ycombinator.com/companies/endpoint-health", "https://www.bizprofile.net/ca/palo-alto/endpoint-health-inc", "https://www.linkedin.com/company/endpoint-health"]}}, {"topic": {"value": "Employee count discrepancy", "source_urls": ["https://www.ycombinator.com/companies/endpoint-health", "https://www.linkedin.com/company/endpoint-health", "https://pitchbook.com/profiles/company/436157-11"]}, "detail": {"value": "YC reports 23; PitchBook 18 (2024); LinkedIn 7; BounceWatch 16; MTEC 1-50 range", "source_urls": ["https://yc-oss.github.io/api/batches/winter-2019/endpoint-health.json", "https://pitchbook.com/profiles/company/436157-11", "https://www.linkedin.com/company/endpoint-health", "https://bouncewatch.com/company/endpoint-health", "https://mtec-sc.org/life-sciences/endpoint-health"]}}, {"topic": {"value": "Funding round classification", "source_urls": ["https://www.businesswire.com/news/home/20220601006271/en/Endpoint-Health-Raises-%2452-Million-in-Financing-to-Expand-and-Progress-Precision-Immunology-Pipeline", "https://tracxn.com/d/companies/endpointhealth/__xxd0zRV_b7rAB4LgCSbRSrycWdrzY7ofABsG5p7t5WY"]}, "detail": {"value": "Business Wire labels $52M as Series A; Tracxn labels company Series C and reports 4 rounds totaling $64M without full round detail publicly available", "source_urls": ["https://www.businesswire.com/news/home/20220601006271/en/Endpoint-Health-Raises-%2452-Million-in-Financing-to-Expand-and-Progress-Precision-Immunology-Pipeline", "https://tracxn.com/d/companies/endpointhealth/__xxd0zRV_b7rAB4LgCSbRSrycWdrzY7ofABsG5p7t5WY"]}}, {"topic": {"value": "Founder departure vs company site", "source_urls": ["https://endpoint.health/our-company/", "https://www.diegorey.com/", "https://theorg.com/org/papa/org-chart/jeff-osborn"]}, "detail": {"value": "Company site still lists Diego Rey as CSO and Jeff Osborn as CTO; Diego Rey personal site shows CEO of Gemini Therapeutics; Jeff Osborn at Papa since Feb 2023", "source_urls": ["https://endpoint.health/our-company/", "https://www.diegorey.com/", "https://theorg.com/org/papa/org-chart/jeff-osborn"]}}, {"topic": {"value": "Founder name spelling", "source_urls": ["https://endpoint.health/our-company/", "https://tracxn.com/d/companies/endpointhealth/__xxd0zRV_b7rAB4LgCSbRSrycWdrzY7ofABsG5p7t5WY"]}, "detail": {"value": "Leonardo Teixeira on company site vs Leonardo Maestri Teixeira on Tracxn and LinkedIn", "source_urls": ["https://endpoint.health/our-company/", "https://tracxn.com/d/companies/endpointhealth/__xxd0zRV_b7rAB4LgCSbRSrycWdrzY7ofABsG5p7t5WY", "https://www.linkedin.com/company/endpoint-health"]}}, {"topic": {"value": "Website domain inconsistency", "source_urls": ["https://endpoint.health/", "https://endpointhealth.com/", "https://www.linkedin.com/company/endpoint-health"]}, "detail": {"value": "endpoint.health used on early press releases and company pages; endpointhealth.com used on YC and later Business Wire releases; LinkedIn lists endpointhealth.godaddysites.com as homepage", "source_urls": ["https://www.businesswire.com/news/home/20200713005154/en/Endpoint-Health-Launches-with-Mission-to-Bring-Life-Saving-Targeted-Therapies-to-Patients-with-Critical-Illnesses", "https://yc-oss.github.io/api/batches/winter-2019/endpoint-health.json", "https://www.linkedin.com/company/endpoint-health"]}}, {"topic": {"value": "Clinical trial progress gap", "source_urls": ["https://www.businesswire.com/news/home/20220223006379/en/Endpoint-Health-Enters-into-Global-Collaboration-and-Licensing-Agreement-with-Grifols", "https://www.businesswire.com/news/home/20221004005369/en/Endpoint-Health-Unveils-Precision-Immunology-Program-to-Address-Tissue-Factor-Mediated-Inflammation-in-Autoimmune-Diseases"]}, "detail": {"value": "2022 announcements targeted IND/IDE submissions and Phase II for Antithrombin III and 2023 IND for EP004; no public confirmation of trial initiation or FDA approvals found in sourced materials", "source_urls": ["https://www.businesswire.com/news/home/20220223006379/en/Endpoint-Health-Enters-into-Global-Collaboration-and-Licensing-Agreement-with-Grifols", "https://www.businesswire.com/news/home/20221004005369/en/Endpoint-Health-Unveils-Precision-Immunology-Program-to-Address-Tissue-Factor-Mediated-Inflammation-in-Autoimmune-Diseases"]}}, {"topic": {"value": "YC batch timing vs stealth launch", "source_urls": ["https://www.ycombinator.com/companies/endpoint-health", "https://www.businesswire.com/news/home/20200713005154/en/Endpoint-Health-Launches-with-Mission-to-Bring-Life-Saving-Targeted-Therapies-to-Patients-with-Critical-Illnesses"]}, "detail": {"value": "YC batch Winter 2019 but public stealth exit and $12M financing announced July 2020, roughly 18 months after batch", "source_urls": ["https://www.ycombinator.com/companies/endpoint-health", "https://www.businesswire.com/news/home/20200713005154/en/Endpoint-Health-Launches-with-Mission-to-Bring-Life-Saving-Targeted-Therapies-to-Patients-with-Critical-Illnesses"]}}]]
- source urls
- ["https://bouncewatch.com/company/endpoint-health", "https://endpoint.health/", "https://endpoint.health/our-company/", "https://endpointhealth.com/", "https://ghicfunds.org/2022/06/02/ghic-adds-endpoint-health-to-global-health-security-portfolio", "https://mtec-sc.org/life-sciences/endpoint-health", "https://pitchbook.com/profiles/company/436157-11", "https://theorg.com/org/papa/org-chart/jeff-osborn", "https://tracxn.com/d/companies/endpointhealth/__xxd0zRV_b7rAB4LgCSbRSrycWdrzY7ofABsG5p7t5WY", "https://tracxn.com/d/companies/iconictherapeutics/__h5QBguRvSNHOKBe8J3Xv0NUksmG3iAFoCq7y5gVzsHU", "https://www.bizprofile.net/ca/palo-alto/endpoint-health-inc", "https://www.businesswire.com/news/home/20200713005154/en/Endpoint-Health-Launches-with-Mission-to-Bring-Life-Saving-Targeted-Therapies-to-Patients-with-Critical-Illnesses", "https://www.businesswire.com/news/home/20220223006379/en/Endpoint-Health-Enters-into-Global-Collaboration-and-Licensing-Agreement-with-Grifols", "https://www.businesswire.com/news/home/20220601006271/en/Endpoint-Health-Raises-%2452-Million-in-Financing-to-Expand-and-Progress-Precision-Immunology-Pipeline", "https://www.businesswire.com/news/home/20221004005369/en/Endpoint-Health-Unveils-Precision-Immunology-Program-to-Address-Tissue-Factor-Mediated-Inflammation-in-Autoimmune-Diseases", "https://www.diegorey.com/", "https://www.forbes.com/sites/katiejennings/2020/07/13/exclusive-endpoint-health-launches-to-help-hospitals-treat-critically-ill-patients/", "https://www.grifols.com/en/view-news/-/news/grifols-signs-global-collaboration-agreement-with-endpoint-health-to-develop-and-commercialize-antithrombin-iii-for-sepsis", "https://www.linkedin.com/company/endpoint-health", "https://www.ycombinator.com/companies/endpoint-health", "https://yc-oss.github.io/api/batches/winter-2019/endpoint-health.json"]